{"schema_version":"secwatch.filing_event.v1","accession":"0000875320-23-000023","form_type":"8-K","ticker":"VRTX","cik":"0000875320","company_name":"VERTEX PHARMACEUTICALS INC / MA","filed_at":"2023-10-05T23:59:59+00:00","discovered_at":"2026-05-14T18:03:32.210856+00:00","generated_at":"2026-06-10T04:25:10.029242+00:00","sec_items":["5.02"],"event_type":"leadership","sentiment":"neutral","materiality_score":0.25,"calibrated_materiality_score":0.25,"confidence":"high","headline":"Vertex appoints Michel Lagarde to board as tenth director","bullets":["Michel Lagarde appointed to Vertex board effective Oct 5, 2023; board expands to 10.","Lagarde is EVP and COO of Thermo Fisher Scientific; background in pharma services and private equity.","Received $400,000 RSU award vesting in October 2024; standard non-employee director compensation."],"urls":{"canonical":"https://secwatch.observer/filing/0000875320-23-000023","json":"https://secwatch.observer/filing/0000875320-23-000023.json","markdown":"https://secwatch.observer/filing/0000875320-23-000023.md","text":"https://secwatch.observer/filing/0000875320-23-000023.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/875320/000087532023000023/0000875320-23-000023-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/875320/000087532023000023/vrtx-20231003.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-10T04:25:10.029242+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"a24df34873","claim":"Michel Lagarde was appointed as Director at VERTEX PHARMACEUTICALS INC / MA.","evidence_excerpt":"On October 3, 2023, Michel Lagarde was appointed as a new member of the board of directors (the “Board”) of Vertex Pharmaceuticals Incorporated (the “Company”), effective on October 5, 2023.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/875320/000087532023000023/0000875320-23-000023-index.htm","confidence":1.0,"family_label":"Executive change","details":[{"label":"Action","value":"appointed"},{"label":"Role","value":"Director"}],"fact_type":"executive_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}